The Revised International Prognostic Scoring System (IPSS-R) is not predictive of survival in patients with secondary myelodysplastic syndromes | Synapse

⌘+K

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1The APLC 2025 consensus recommendations on the assessment and management of measurable residual disease in adults with acute lymphoblastic leukemiaLeukemia & lymphoma/Leukemia and lymphoma · 2026
2Lower baseline eosinophil counts are associated with inferior survival in Mantle cell lymphomaLeukemia & lymphoma/Leukemia and lymphoma · 2026
3Single-Cell RNA sequencing analysis of cellular heterogeneity and microenvironment-driven signaling networks in acute myeloid leukemiaLeukemia & lymphoma/Leukemia and lymphoma · 2026
4Chronic myelomonocytic leukemia associated with lymphoid neoplasmsLeukemia & lymphoma/Leukemia and lymphoma · 2026
5Care pathway of patients with second-line large B-cell lymphoma treated with CAR T-cell therapies in FranceLeukemia & lymphoma/Leukemia and lymphoma · 2026

More from Leukemia & lymphoma/Leukemia and lymphoma

More from Cleveland Clinic